AAAAAA

   
Results: 1-11 |
Results: 11
The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2
Authors: Schimmer, AD Hedley, DW Chow, S Pham, NA Chakrabartty, A Bouchard, D Mak, TW Trus, MR Minden, MD
Citation: Ad. Schimmer et al., The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2, CELL DEAT D, 8(7), 2001, pp. 725-733
Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin
Authors: Wong, WWL Tan, MM Xia, ZL Dimitroulakos, J Minden, MD Penn, LZ
Citation: Wwl. Wong et al., Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin, CLIN CANC R, 7(7), 2001, pp. 2067-2075
BAD induces apoptosis in cells over-expressing Bcl-2 or Bcl-xL without loss of mitochondrial membrane potential
Authors: Schimmer, AD Hedley, DW Pham, NA Chow, S Minden, MD
Citation: Ad. Schimmer et al., BAD induces apoptosis in cells over-expressing Bcl-2 or Bcl-xL without loss of mitochondrial membrane potential, LEUK LYMPH, 42(3), 2001, pp. 429-443
Lovastatin induced control of blast cell growth in an elderly patient withacute myeloblastic leukemia
Authors: Minden, MD Dimitroulakos, J Nohynek, D Penn, LZ
Citation: Md. Minden et al., Lovastatin induced control of blast cell growth in an elderly patient withacute myeloblastic leukemia, LEUK LYMPH, 40(5-6), 2001, pp. 659-662
Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells
Authors: Xia, Z Tan, MM Wong, WWL Dimitroulakos, J Minden, MD Penn, LZ
Citation: Z. Xia et al., Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells, LEUKEMIA, 15(9), 2001, pp. 1398-1407
Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view
Authors: Schimmer, AD Hedley, DW Penn, LZ Minden, MD
Citation: Ad. Schimmer et al., Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view, BLOOD, 98(13), 2001, pp. 3541-3553
Antileukemic effects of buthionine sulfoximine (BSO) (NSC 326231) in vivo:A pilot study in acute myeloblastic leukemia
Authors: Curtis, J Hedley, DW Minden, MD Moore, MA McCulloch, EA
Citation: J. Curtis et al., Antileukemic effects of buthionine sulfoximine (BSO) (NSC 326231) in vivo:A pilot study in acute myeloblastic leukemia, HEMAT BLOOD, 40, 2001, pp. 257-264
Osteoporosis after blood and marrow transplantation: Clinical aspects
Authors: Schimmer, AD Minden, MD Keating, A
Citation: Ad. Schimmer et al., Osteoporosis after blood and marrow transplantation: Clinical aspects, BIOL BLOOD, 6(2A), 2000, pp. 175-181
Lovastatin induces a pronounced differentiation response in acute myeloid leukemias
Authors: Dimitroulakos, J Thai, S Wasfy, GH Hedley, DW Minden, MD Penn, LZ
Citation: J. Dimitroulakos et al., Lovastatin induces a pronounced differentiation response in acute myeloid leukemias, LEUK LYMPH, 40(1-2), 2000, pp. 167
Regulation of drug sensitivity by ribosomal protein S3a
Authors: Hu, ZB Minden, MD McCulloch, EA
Citation: Zb. Hu et al., Regulation of drug sensitivity by ribosomal protein S3a, BLOOD, 95(3), 2000, pp. 1047-1055
Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach
Authors: Dimitroulakos, J Nohynek, D Backway, KL Hedley, DW Yeger, H Freedman, MH Minden, MD Penn, LZ
Citation: J. Dimitroulakos et al., Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach, BLOOD, 93(4), 1999, pp. 1308-1318
Risultati: 1-11 |